RheoCarti awarded CHF 150,000 to advance hydrogel-articulated joint implants
RheoCarti, a Zurich-based startup, received CHF 150,000 from Venture Kick to develop titanium–hydrogel resurfacing joint implants that mimic natural cartilage properties. The company aims to reduce implant complications in younger, active patients and plans to first enter the veterinary market before expanding to human applications. The funding will support team strengthening, manufacturing readiness, and market development.
RheoCarti, a Zurich-based startup, received CHF 150,000 from Venture Kick to develop titanium–hydrogel resurfacing joint implants that mimic natural cartilage properties. The company aims to reduce implant complications in younger, active patients and plans to first enter the veterinary market before expanding to human applications. The funding will support team strengthening, manufacturing readiness, and market development.
This project contributes to Switzerland’s broader innovation ecosystem, though it does not directly involve AI.
Original source record. Open the original record to verify the underlying announcement.